Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Thoracic Cancer|October 28, 2020
Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancerZhe Zhao, Kailun Fei, Hua Bai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2023
CD74/SLC34A2-ROS1 Fusion Variants Involving the Transmembrane Region Predict Poor Response to Crizotinib in NSCLC Independent of TP53 MutationsWeihua Li, Kailun Fei, Lei Guo, et al.
Chinese Medical Journal Pulmonary and Critical Care Medicine|October 20, 2025
Burden of chemotherapy-induced myelosuppression (CIM) in Chinese patients with extensive-stage small cell lung cancer (ES-SCLC): A retrospective real-world studyKailun Fei, Wenjing Yang, Jianchun Duan, et al.
Zhonghua Wei Chang Wai Ke Za Zhi = Chinese Journal of Gastrointestinal Surgery|August 25, 2017
[Comparison of intra-abdominal infection between intracorporeal anastomosis and extracorporeal anastomosis in patients undergoing laparoscopic right hemicolectomy]Xiyu Sun, Huizhong Qiu, Kailun Fei, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2020
Dynamics of peripheral T cell clones during PD-1 blockade in non-small cell lung cancerFan Zhang, Hua Bai, Ranran Gao, et al.
BMC Cancer|June 17, 2026
Developing a quality evaluation indicator system for lung cancer diagnosis and treatment: a modified Delphi method studyLiming Shi, Kailun Fei, Meicen Liu, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 14, 2018
Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after ChemotherapyRui Ju, Kailun Fei, Siang Li, et al.
Translational Oncology|June 30, 2021
TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinibRuofei Yu, Hua Bai, Tangai Li, et al.
Cell Reports Methods|September 22, 2023
Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapyJie Zhao, Yiting Dong, Hua Bai, et al.
Frontiers in Genetics|March 8, 2021
Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung AdenocarcinomasSijin Sun, Kailun Fei, Guochao Zhang, et al.
Pageof 4